Shanghai Orsin Medical Technology Co., Ltd.
Product Details
Place of Origin: China
Brand Name: Orsin
Payment & Shipping Terms
Minimum Order Quantity: 100
Price: Negotiation
Payment Terms: L/C, D/A, D/P, T/T, Western Union
Material: |
Glass And Plastic |
Feature: |
Customization |
Capacity: |
Customization |
Product Name: |
DHA Sterile And Safe |
Clinical Use: |
Blood Bank |
Characteristic: |
Liquid Biopsy |
Material: |
Glass And Plastic |
Feature: |
Customization |
Capacity: |
Customization |
Product Name: |
DHA Sterile And Safe |
Clinical Use: |
Blood Bank |
Characteristic: |
Liquid Biopsy |
| Attribute | Value |
|---|---|
| Material | Glass and plastic |
| Feature | Customization |
| Capacity | Customization |
| Product name | DHA Sterile And Safe |
| Clinical Use | Blood bank |
| Characteristic | Liquid Biopsy |
Orsin Medical Technology Cell-Free DNA (cfDNA) Extraction Kit
Orsin Medical Technology's cfDNA Extraction Kit provides a high-efficiency, rapid, and contamination-free solution for isolating circulating cell-free DNA from plasma, serum, and other liquid biopsies. Utilizing advanced magnetic bead-based technology, the kit ensures high recovery rates of ultra-short cfDNA fragments (50-300 bp), making it ideal for NIPT, liquid biopsy, and cancer monitoring. With optimized protocols for minimal genomic DNA contamination and compatibility with downstream NGS, qPCR, and ddPCR applications, Orsin's kit delivers high-purity, stable cfDNA for precision diagnostics and research.
Ideal for clinical research, oncology, and prenatal testing, Orsin's cfDNA Extraction Kit ensures reliable performance for cutting-edge molecular diagnostics.
| Parameter | Description/Options |
|---|---|
| Tube Cap Color | Red, Lavender (Purple), Green, Gray, Blue, Yellow, Black, etc. |
| Additive Type | None (Clot activator), EDTA, Heparin, Sodium Citrate, Sodium Fluoride, etc. |
| Clinical Use | Serum separation, Hematology, Coagulation, Chemistry, Glucose, Blood Bank, etc. |
| Nominal Volume | 2ml, 3ml, 4ml, 5ml, 6ml, 7ml, 8ml, 10ml, etc. |
| Draw Volume Range | ±10% of nominal volume (e.g., 4.5-5.5ml for 5ml tube) |
| Tube Diameter | 13mm, 16mm (standard adult size) |
| Tube Length | 75mm, 100mm, etc. |
| Material | PET plastic, Glass |
| Sterilization | Gamma irradiation, EO Gas |
| Expiry Period | Typically 12-36 months (from date of manufacture) |
| Hemolysis Rate | ≤0.1% (for most chemistry tubes) |
| Clotting Time | 30 mins (for serum tubes with clot activator) |
| Centrifuge Speed | 1300-2200g (tube material dependent) |
| Safety Features | Hemogard™ closure, BD-PTS, Needle protection system |
| Certifications | ISO 6710, CE Marked, FDA 510(k) |
| Cap Color | Additive | Mixing | Inversion Count | Clinical Applications |
|---|---|---|---|---|
| Red | None/Clot activator | 5× | 5-6 | Serum chemistry, Immunology |
| Lavender | K2/K3 EDTA | 8-10× | 8-10 | Hematology (CBC, Blood Smear) |
| Green | Lithium Heparin | 8-10× | 8-10 | Plasma chemistry, STAT tests |
| Gray | NaF/K Oxalate | 8-10× | 8-10 | Glucose tolerance, Alcohol tests |
| Blue | Sodium Citrate | 3-4× | 3-4 | Coagulation tests (PT, APTT) |
Scenario: Blood tests for routine diagnostics (CBC, biochemistry, coagulation) in outpatient/inpatient settings.
Adaptability:
Scenario: Rapid analysis of blood gases, electrolytes, and cardiac markers (e.g., troponin) in urgent care.
Adaptability:
Scenario: Genomics (DNA/RNA extraction), proteomics, and drug metabolism research.
Adaptability:
Scenario: Blood component separation (plasma, RBCs, platelets), blood typing, and cross-matching.
Adaptability:
Scenario: Low-volume collection for neonates or patients with fragile veins.
Adaptability:
Scenario: Large-scale screening (e.g., HIV, hepatitis, metabolic syndrome).
Adaptability:
Scenario: Community clinics, home healthcare, and remote area testing.
Adaptability:
